Case Study: Top 10 Pharmaceutical Company achieves record‑breaking enrollment (700 patients in under 6 weeks) with Medable

Record-breaking enrollment achieved in weight-loss study

Top 10 Pharmaceutical Company engaged Medable to accelerate enrollment for a Phase III diabetes (weight‑loss) trial, seeking to shorten the participant startup timeline amid intense competition in the chronic weight‑management market. The client turned to Medable’s patient‑focused platform and services to refine technology and screening processes and get the study underway faster than any prior trial.

Medable partnered with the sponsor to analyze startup workflows, implement new patient screening processes and technology standards, and streamline site and study‑team communication. The result was record‑breaking enrollment—the fastest in the client’s history—with over 1,000 patients screened and 700 enrolled in just under six weeks—while improving efficiency, reducing back‑and‑forth, and creating reusable core processes for future studies.